Investor Relations

Investor FAQ

Show all

Intersect is a commercial stage drug-device company committed to improving the quality of life for patients with ear, nose and throat conditions.  Our initial products, PROPEL and PROPEL mini, are the first and only drug-eluting implants approved by the U.S. Food and Drug Administration for use in patients with chronic sinusitis.  Use of our PROPEL implants is clinically proven to improve surgical outcomes by maintaining the open pathways created in surgery and reducing the need for oral steroids and additional surgical procedures. Based in Menlo Park, California, Intersect’s products are available in the United States.
Intersect’s ticker is “XENT”.
Intersect trades on the NASDAQ Stock Market under the ticker symbol “XENT”.
No, Intersect does not offer a direct stock purchase program.
Intersect’s SEC filings are available by selecting the “Financials & Filings” section of our “Investors” page on our website or through the SEC’s website (www.sec.gov).
Intersect’s fiscal year ends December 31st.
The annual stockholders meeting date has been set for June 2, 2016 at 10:00 A.M. Pacific time. 
Intersect’s independent auditor is EY.
Intersect uses Computershare as its transfer agent.  You can contact them at:
Computershare
P.O. Box 30170
College Station, TX 77842-3170
1-800-736-3001 (US, Canada, Puerto Rico)
1-781-575-3100 (non-US)
web.queries@computershare.com
Intersect’s outside legal counsel is Cooley LLP.
No, Intersect does not pay a dividend at this time.
The biographies of Intersect’s officers and directors are available in the “Corporate Governance” section of our website.
Please see the “Events & Presentations” section of our website for a listing of upcoming earnings announcements and other key events.
You can contact Intersect’s Investor Relations via email by clicking here.
The Company’s headquarters is located in Menlo Park, California.
Intersect ENT, Inc. was incorporated in the state of Delaware in October 2003.
If your shares are held in street name (by your broker), you must notify the securities firm holding your stock.  If you hold stock certificates in your name, address changes should be submitted in writing by U.S. Mail to our transfer agent: Computershare,  P.O. Box 30170,  College Station, TX  77842-3170; 1-800-736-3001.
If you hold stock certificates in your name, please contact our transfer agent regarding the replacement of lost certificates:  Computershare,  P.O. Box 30170,  College Station, TX  77842-3170; 1-800-736-3001